secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2023-01-12T23:59:59+00:00
Accession:  0001493152-23-001271
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Bioscience receives Nasdaq deficiency notice for minimum bid price non-compliance
--------------------------------------------------------------------------------

- On Jan 11, 2023, INVO received Nasdaq notice of non-compliance with minimum bid price of $1.00 per share.
- Company has 180 days, until July 10, 2023, to regain compliance by closing at $1.00 for 10 consecutive business days.
- If non-compliant after first period, Nasdaq may grant a second 180-day period if other listing standards are met.
- Failure to cure could lead to delisting; company may appeal Nasdaq's determination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223001271/0001493152-23-001271-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223001271/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-001271

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer